Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan P Piccini

Showing results (481-490 of 538) with videos related to

Pageof 54
Sort By:
BMJ Open|December 24, 2017
Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulationKeith A A Fox, Joseph E Lucas, Karen S Pieper, et al.
American Heart Journal|November 12, 2019
Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillationZak Loring, Peter Shrader, Larry A Allen, et al.
Heart (British Cardiac Society)|September 20, 2018
B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillationTaku Inohara, Sunghee Kim, Karen Pieper, et al.
Heart Rhythm O2|March 30, 2026
A randomized controlled trial of pulsed field ablation vs antiarrhythmic therapy as a first-line treatment for persistent atrial fibrillation: The AVANT GUARD trial rationale and designOussama M Wazni, Kyoung-Ryul Julian Chun, Anish Amin, et al.
Journal of the American Heart Association|February 18, 2018
Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)Benjamin A Steinberg, Peter Shrader, Karen Pieper, et al.
Heart Rhythm|February 27, 2026
Impact of Atrial Fibrillation Burden on Quality of Life and Prediction of Healthcare Utilization: Primary Results from the DEFINE AFib StudyJonathan P Piccini, Andrea M Russo, James Peacock, et al.
Circulation. Arrhythmia and Electrophysiology|July 25, 2020
Procedural Patterns and Safety of Atrial Fibrillation Ablation: Findings From Get With The Guidelines-Atrial FibrillationZak Loring, DaJuanicia N Holmes, Roland A Matsouaka, et al.
Nature Reviews. Cardiology|March 31, 2025
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolismDavide Capodanno, John H Alexander, M Cecilia Bahit, et al.
JAMA Cardiology|July 21, 2016
Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary SyndromePaul L Hess, Daniel M Wojdyla, Sana M Al-Khatib, et al.
Journal of Cardiovascular Electrophysiology|January 31, 2025
Use of a Stylet Driven Lead With a Flexible Neck for Left Bundle Branch Area Pacing: A Single Center ExperienceSara A Coles, Ilya Y Shadrin, Sana M Al-Khatib, et al.
Pageof 54

Showing results (481-490 of 538) with videos related to

Sort By:
Pageof 54
BMJ Open|December 24, 2017
Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulationKeith A A Fox, Joseph E Lucas, Karen S Pieper, et al.
American Heart Journal|November 12, 2019
Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillationZak Loring, Peter Shrader, Larry A Allen, et al.
Heart (British Cardiac Society)|September 20, 2018
B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillationTaku Inohara, Sunghee Kim, Karen Pieper, et al.
Heart Rhythm O2|March 30, 2026
A randomized controlled trial of pulsed field ablation vs antiarrhythmic therapy as a first-line treatment for persistent atrial fibrillation: The AVANT GUARD trial rationale and designOussama M Wazni, Kyoung-Ryul Julian Chun, Anish Amin, et al.
Journal of the American Heart Association|February 18, 2018
Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)Benjamin A Steinberg, Peter Shrader, Karen Pieper, et al.
Heart Rhythm|February 27, 2026
Impact of Atrial Fibrillation Burden on Quality of Life and Prediction of Healthcare Utilization: Primary Results from the DEFINE AFib StudyJonathan P Piccini, Andrea M Russo, James Peacock, et al.
Circulation. Arrhythmia and Electrophysiology|July 25, 2020
Procedural Patterns and Safety of Atrial Fibrillation Ablation: Findings From Get With The Guidelines-Atrial FibrillationZak Loring, DaJuanicia N Holmes, Roland A Matsouaka, et al.
Nature Reviews. Cardiology|March 31, 2025
Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolismDavide Capodanno, John H Alexander, M Cecilia Bahit, et al.
JAMA Cardiology|July 21, 2016
Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary SyndromePaul L Hess, Daniel M Wojdyla, Sana M Al-Khatib, et al.
Journal of Cardiovascular Electrophysiology|January 31, 2025
Use of a Stylet Driven Lead With a Flexible Neck for Left Bundle Branch Area Pacing: A Single Center ExperienceSara A Coles, Ilya Y Shadrin, Sana M Al-Khatib, et al.
Pageof 54